BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Veness MJ, Porceddu S, Palme CE, Morgan GJ. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck. 2007;29:621-631. [PMID: 17230560 DOI: 10.1002/hed.20576] [Cited by in Crossref: 139] [Cited by in F6Publishing: 121] [Article Influence: 9.9] [Reference Citation Analysis]
Number Citing Articles
1 Kolk A, Wolff KD, Smeets R, Kesting M, Hein R, Eckert AW. Melanotic and non-melanotic malignancies of the face and external ear - A review of current treatment concepts and future options. Cancer Treat Rev 2014;40:819-37. [PMID: 24814015 DOI: 10.1016/j.ctrv.2014.04.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
2 Iseli TA, Harris G, Dean NR, Iseli CE, Rosenthal EL. Outcomes of static and dynamic facial nerve repair in head and neck cancer. Laryngoscope 2010;120:478-83. [PMID: 20131366 DOI: 10.1002/lary.20789] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
3 Flukes S, Long S, Lohia S, Barker CA, Dunn LA, Cracchiolo J, Ganly I, Patel S, Cohen MA. Metastatic Cutaneous Squamous Cell Carcinoma Involving the Parotid Gland: Experience Outside of the Sun Belt. OTO Open 2021;5:2473974X20984720. [PMID: 33474523 DOI: 10.1177/2473974X20984720] [Reference Citation Analysis]
4 Durbec M, Couloigner V, Tronche S, Albert S, Kanitakis J, Ltaief Boudrigua A, Malard O, Maubec E, Mourrain Langlois E, Navailles B, Peuvrel L, Phulpin B, Thimonier J, Disant F, Dolivet G. Guidelines of the French Society of Otorhinolaryngology (SFORL), short version. Extension assessment and principles of resection in cutaneous head and neck tumors. European Annals of Otorhinolaryngology, Head and Neck Diseases 2014;131:375-83. [DOI: 10.1016/j.anorl.2014.06.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
5 Hirshoren N, Olayos E, Herschtal A, Ravi Kumar AS, Gyorki DE. Preoperative Positron Emission Tomography for Node-Positive Head and Neck Cutaneous Squamous Cell Carcinoma. Otolaryngol Head Neck Surg 2018;158:122-6. [DOI: 10.1177/0194599817731735] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
6 Jenkins G, Smith A, Kanatas A, Houghton D, Telfer M. Anatomical restrictions in the surgical excision of scalp squamous cell carcinomas: does this affect local recurrence and regional nodal metastases? International Journal of Oral and Maxillofacial Surgery 2014;43:142-6. [DOI: 10.1016/j.ijom.2013.08.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
7 Moeckelmann N, Ebrahimi A, Dirven R, Liu J, Low T, Gupta R, Ashford B, Ch’ng S, Palme CE, Clark JR. Analysis and Comparison of the 8th Edition American Joint Committee on Cancer (AJCC) Nodal Staging System in Cutaneous and Oral Squamous Cell Cancer of the Head and Neck. Ann Surg Oncol 2018;25:1730-6. [DOI: 10.1245/s10434-018-6340-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
8 Rabinovics N, Mizrachi A, Hadar T, Ad-El D, Feinmesser R, Guttman D, Shpitzer T, Bachar G. Cancer of the head and neck region in solid organ transplant recipients. Head Neck 2014;36:181-6. [PMID: 23554129 DOI: 10.1002/hed.23283] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
9 Kreppel M, Krakowezki A, Kreppel B, Drebber U, Wedemeyer I, Mauch C, Zöller JE, Scheer M. Podoplanin expression in cutaneous head and neck squamous cell carcinoma-prognostic value and clinicopathologic implications: Podoplanin in Cutaneous Head Neck Cancer. J Surg Oncol 2013;107:376-83. [DOI: 10.1002/jso.23238] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
10 Hashimoto K, Yasumatsu R, Toh S, Shiratsuchi H, Yoshida T, Nishiyama K, Yoshikawa H, Nakashima T, Nakagawa T. Patterns of lymphatic spread and the management of eyelid carcinomas. Auris Nasus Larynx 2016;43:666-71. [DOI: 10.1016/j.anl.2016.02.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
11 Veness M, Howle J. Management of Nodal Metastases. In: Schmults CD, editor. High-Risk Cutaneous Squamous Cell Carcinoma. Berlin: Springer Berlin Heidelberg; 2016. pp. 189-211. [DOI: 10.1007/978-3-662-47081-7_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Hartl DM, Brasnu DF, Shah JP, Hinni ML, Takes RP, Olsen KD, Kowalski LP, Rodrigo JP, Strojan P, Wolf GT, Rinaldo A, Suárez C, Mendenhall WM, Paleri V, Forastiere AA, Werner JA, Ferlito A. Is open surgery for head and neck cancers truly declining? Eur Arch Otorhinolaryngol 2013;270:2793-802. [DOI: 10.1007/s00405-012-2322-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
13 Mourouzis C, Boynton A, Grant J, Umar T, Wilson A, Macpheson D, Pratt C. Cutaneous head and neck SCCs and risk of nodal metastasis - UK experience. J Craniomaxillofac Surg 2009;37:443-7. [PMID: 19713116 DOI: 10.1016/j.jcms.2009.07.007] [Cited by in Crossref: 100] [Cited by in F6Publishing: 82] [Article Influence: 8.3] [Reference Citation Analysis]
14 Brunner M, Ng BC, Veness MJ, Clark JR. Comparison of the AJCC N staging system in mucosal and cutaneous squamous head and neck cancer. Laryngoscope 2014;124:1598-602. [PMID: 24307576 DOI: 10.1002/lary.24549] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
15 Daniels CP, Bressel M, Corry J, Cole A, Chua MS, Tiong A, Hirshoren N, Dixon B, Mcdowell L. Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell Carcinoma. Practical Radiation Oncology 2020;10:29-35. [DOI: 10.1016/j.prro.2019.09.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Burton KA, Ashack KA, Khachemoune A. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease. Am J Clin Dermatol 2016;17:491-508. [PMID: 27358187 DOI: 10.1007/s40257-016-0207-3] [Cited by in Crossref: 114] [Cited by in F6Publishing: 115] [Article Influence: 28.5] [Reference Citation Analysis]
17 Assadsangabi R, Babaei R, Songco C, Ivanovic V, Bobinski M, Chen YJ, Nabavizadeh SA. Multimodality oncologic evaluation of superficial neck and facial lymph nodes. Radiol Med 2021;126:1074-84. [PMID: 33993441 DOI: 10.1007/s11547-021-01367-3] [Reference Citation Analysis]
18 Allen J, Stolle L. Utility of sentinel node biopsy in patients with high-risk cutaneous squamous cell carcinoma. European Journal of Surgical Oncology (EJSO) 2015;41:197-200. [DOI: 10.1016/j.ejso.2014.10.055] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
19 Staackmann C, Schild SE, Rades D. Palliative Radiotherapy for Cutaneous Squamous Cell Carcinoma of the Head-and-Neck Region. In Vivo 2021;35:2283-8. [PMID: 34182507 DOI: 10.21873/invivo.12501] [Reference Citation Analysis]
20 Clark RR, Soutar DS. Lymph node metastases from auricular squamous cell carcinoma. A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg 2008;61:1140-7. [PMID: 18675609 DOI: 10.1016/j.bjps.2008.04.036] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
21 Perry J, Minaei E, Engels E, Ashford BG, McAlary L, Clark JR, Gupta R, Tehei M, Corde S, Carolan M, Ranson M. Thulium oxide nanoparticles as radioenhancers for the treatment of metastatic cutaneous squamous cell carcinoma. Phys Med Biol 2020;65:215018. [PMID: 32726756 DOI: 10.1088/1361-6560/abaa5d] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Wilkie MD, Lancaster J, Roland NJ, Jones TM. Elective management of regional nodal basins in cutaneous squamous cell carcinoma of the head and neck: Controversies and contemporary perspectives. Oral Oncol 2021;120:105432. [PMID: 34218060 DOI: 10.1016/j.oraloncology.2021.105432] [Reference Citation Analysis]
23 Badlani J, Gupta R, Smith J, Ashford B, Ch'ng S, Veness M, Clark J. Metastases to the parotid gland - A review of the clinicopathological evolution, molecular mechanisms and management. Surgical Oncology 2018;27:44-53. [DOI: 10.1016/j.suronc.2017.11.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
24 Deconti RC. Chemotherapy of Squamous Cell Carcinoma of the Skin. Seminars in Oncology 2012;39:145-9. [DOI: 10.1053/j.seminoncol.2012.01.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
25 Watt SA, Pourreyron C, Purdie K, Hogan C, Cole CL, Foster N, Pratt N, Bourdon JC, Appleyard V, Murray K, Thompson AM, Mao X, Mein C, Bruckner-Tuderman L, Evans A, McGrath JA, Proby CM, Foerster J, Leigh IM, South AP. Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma. Oncogene 2011;30:4666-77. [PMID: 21602893 DOI: 10.1038/onc.2011.180] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
26 Ch'ng S, Maitra A, Allison RS, Chaplin JM, Gregor RT, Lea R, Tan ST. Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma. J Surg Oncol 2008;98:101-5. [PMID: 18523982 DOI: 10.1002/jso.21092] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 5.3] [Reference Citation Analysis]
27 Brougham ND, Tan ST. The incidence and risk factors of metastasis for cutaneous squamous cell carcinoma--implications on the T-classification system. J Surg Oncol 2014;110:876-82. [PMID: 25088537 DOI: 10.1002/jso.23731] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
28 Park SW, Eade T, Pang L, Wignall A, Veivers D. Role of neck dissection in metastatic squamous cell carcinoma to the parotid gland. J Laryngol Otol. 2016;130 Suppl 4:S54-S59. [PMID: 27488339 DOI: 10.1017/s0022215116008343] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
29 Genders RE, Weijns ME, Dekkers OM, Plasmeijer EI. Metastasis of cutaneous squamous cell carcinoma in organ transplant recipients and the immunocompetent population: is there a difference? a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2019;33:828-41. [PMID: 30793804 DOI: 10.1111/jdv.15396] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
30 Tomaszewski JM, Gavriel H, Link E, Boodhun S, Sizeland A, Corry J. Aggressive behavior of Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia: Cutaneous SCC in Patients with CLL. The Laryngoscope 2014;124:2043-8. [DOI: 10.1002/lary.24586] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
31 Wermker K, Kluwig J, Schipmann S, Klein M, Schulze H, Hallermann C. Prediction score for lymph node metastasis from cutaneous squamous cell carcinoma of the external ear. European Journal of Surgical Oncology (EJSO) 2015;41:128-35. [DOI: 10.1016/j.ejso.2014.07.039] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
32 Wong WK, Morton RP. Elective management of cervical and parotid lymph nodes in stage N0 cutaneous squamous cell carcinoma of the head and neck: a decision analysis. Eur Arch Otorhinolaryngol 2014;271:3011-9. [DOI: 10.1007/s00405-013-2857-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
33 Ma JH, Wu A, Veness M, Estall V, Hong A, Borg M, James C, Ibbetson J, Ooi C, Weightman W, McColl I, Hamann I, Grieve N, Ozluer S, Salmon P, Nikitins M, Caplash Y, Marshall N, Edwards T, Patterson I, Selva D, Huilgol SC. In-Transit Metastasis From Squamous Cell Carcinoma. Dermatol Surg 2016;42:1285-92. [PMID: 27598442 DOI: 10.1097/DSS.0000000000000864] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
34 Vidovic D, Simms GA, Pasternak S, Walsh M, Peltekian K, Stein J, Helyer LK, Giacomantonio CA. Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient. Front Immunol 2021;12:678028. [PMID: 34122442 DOI: 10.3389/fimmu.2021.678028] [Reference Citation Analysis]
35 . Current world literature. Curr Opin Otolaryngol Head Neck Surg 2009;17:132-41. [PMID: 19363348 DOI: 10.1097/MOO.0b013e32832ad5ad] [Reference Citation Analysis]
36 Veness MJ, Kian Ang K. Cutaneous Carcinoma. Clinical Radiation Oncology. Elsevier; 2012. pp. 757-69. [DOI: 10.1016/b978-1-4377-1637-5.00039-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Cheung MC, Franzmann E, Sola JE, Pincus DJ, Koniaris LG. A comprehensive analysis of parotid and salivary gland cancer: worse outcomes for male gender. J Surg Res. 2011;171:151-158. [PMID: 20189602 DOI: 10.1016/j.jss.2009.11.721] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
38 Lorimer P, Milas Z. Cutaneous manifestations associated with malignancy of the head and neck. Seminars in Oncology 2016;43:353-8. [DOI: 10.1053/j.seminoncol.2016.02.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
39 Hasmat S, Ebrahimi A, Luk PP, Low T(, Mcdowell L, Magarey MJR, Veness M, Gupta R, Clark J. Positive survival trend in metastatic head and neck cutaneous squamous cell carcinoma over four‐decades: Multicenter study. Head & Neck 2019;41:3826-32. [DOI: 10.1002/hed.25912] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
40 Skulsky SL, O'sullivan B, Mcardle O, Leader M, Roche M, Conlon PJ, O'neill JP, W. Eisele D. Review of high‐risk features of cutaneous squamous cell carcinoma and discrepancies between the American Joint Committee on Cancer and NCCN Clinical Practice Guidelines In Oncology. Head Neck 2017;39:578-94. [DOI: 10.1002/hed.24580] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 11.2] [Reference Citation Analysis]
41 Hirshoren N, Ruskin O, Mcdowell LJ, Magarey M, Kleid S, Dixon BJ. Management of Parotid Metastatic Cutaneous Squamous Cell Carcinoma: Regional Recurrence Rates and Survival. Otolaryngol Head Neck Surg 2018;159:293-9. [DOI: 10.1177/0194599818764348] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
42 O'Reilly Zwald F, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011;65:263-79. [PMID: 21763562 DOI: 10.1016/j.jaad.2010.11.063] [Cited by in Crossref: 137] [Cited by in F6Publishing: 102] [Article Influence: 13.7] [Reference Citation Analysis]
43 Clark JR, Rumcheva P, Veness MJ. Analysis and Comparison of the 7th Edition American Joint Committee on Cancer (AJCC) Nodal Staging System for Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck. Ann Surg Oncol 2012;19:4252-8. [DOI: 10.1245/s10434-012-2504-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
44 Ebrahimi A, Moncrieff MD, Clark JR, Shannon KF, Gao K, Milross CG, O'Brien CJ. Predicting the pattern of regional metastases from cutaneous squamous cell carcinoma of the head and neck based on location of the primary. Head Neck 2010;32:1288-94. [PMID: 20091686 DOI: 10.1002/hed.21332] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
45 Sweeny L, Zimmerman T, Carroll WR, Schmalbach CE, Day KE, Rosenthal EL. Head and Neck Cutaneous Squamous Cell Carcinoma Requiring Parotidectomy: Prognostic Indicators and Treatment Selection. Otolaryngol Head Neck Surg 2014;150:610-7. [DOI: 10.1177/0194599814520686] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
46 Turner SJ, Morgan GJ, Palme CE, Veness MJ. Metastatic cutaneous squamous cell carcinoma of the external ear: a high-risk cutaneous subsite. J Laryngol Otol 2010;124:26-31. [DOI: 10.1017/s0022215109991101] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
47 Sollamo EMJ, Ilmonen SK, Virolainen MS, Suominen SHH. Sentinel lymph node biopsy in cN0 squamous cell carcinoma of the lip: A retrospective study: Staging of lip cN0 SCC with sentinel lymph node biopsy. Head Neck 2016;38:E1375-80. [DOI: 10.1002/hed.24230] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
48 Foy JP, Kolb F, Routier E, Cavalcanti A, Lumbroso J, Tomasic G, Mateus C, Temam S, Robert C, Moya-Plana A. Sentinel lymph node biopsy in 33 non-melanoma skin cancers of the head and neck: A twelve-year experience with long-term follow-up. Clin Otolaryngol 2018;43:1148-52. [PMID: 29575799 DOI: 10.1111/coa.13100] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
49 D'souza J, Clark J. Management of the neck in metastatic cutaneous squamous cell carcinoma of the head and neck. Current Opinion in Otolaryngology & Head & Neck Surgery 2011;19:99-105. [DOI: 10.1097/moo.0b013e328343e811] [Cited by in Crossref: 43] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
50 McLean T, Brunner M, Ebrahimi A, Gao K, Ch'ng S, Veness MJ, Clark JR. Concurrent primary and metastatic cutaneous head and neck squamous cell carcinoma: Analysis of prognostic factors. Head Neck 2013;35:1144-8. [PMID: 22907905 DOI: 10.1002/hed.23102] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
51 Kadakia S, Ducic Y, Marra D, Saman M. The role of elective superficial parotidectomy in the treatment of temporal region squamous cell carcinoma. Oral Maxillofac Surg 2016;20:143-7. [DOI: 10.1007/s10006-015-0539-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
52 Czerwonka L, De Santis RJ, Horowitz G, Hong M, Orsini M, Enepekides D, Goldstein DP, Dort J, Higgins K. Staging cutaneous squamous cell carcinoma metastases to the parotid gland. Laryngoscope 2017;127:2063-9. [PMID: 28295401 DOI: 10.1002/lary.26544] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
53 Coombe RF, Lam AK, O'Neill J. Histopathological evaluation of parotid gland neoplasms in Queensland, Australia. J Laryngol Otol 2016;130 Suppl 1:S26-31. [PMID: 26511326 DOI: 10.1017/S0022215115002789] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Laco J, Celakovsky P, Kalfert D, Hornychova H, Rybnikar T, Ryska A. Tumor-to-tumor metastasis: Warthin tumor as a recipient of lung carcinoma and of renal carcinoma - Report of two cases. Pathol Res Pract 2010;206:458-62. [PMID: 19625134 DOI: 10.1016/j.prp.2009.06.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
55 Goh A, Howle J, Hughes M, Veness MJ. Managing patients with cutaneous squamous cell carcinoma metastatic to the axilla or groin lymph nodes: Managing patients with cSCC. Australasian Journal of Dermatology 2010;51:113-7. [DOI: 10.1111/j.1440-0960.2009.00576.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
56 Dean NR, Sweeny L, Magnuson JS, Carroll WR, Robinson D, Desmond RA, Rosenthal EL. Outcomes of recurrent head and neck cutaneous squamous cell carcinoma. J Skin Cancer 2011;2011:972497. [PMID: 21773040 DOI: 10.1155/2011/972497] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
57 Ryan WR, Heaton CM, Wang SJ. Elective regional lymphadenectomy for advanced auricular squamous cell carcinoma. World J Otorhinolaryngol 2013; 3(1): 16-21 [DOI: 10.5319/wjo.v3.i1.16] [Reference Citation Analysis]
58 Schmidt C, Martin JM, Khoo E, Plank A, Grigg R. Outcomes of nodal metastatic cutaneous squamous cell carcinoma of the head and neck treated in a regional center. Head Neck 2015;37:1808-15. [PMID: 24995842 DOI: 10.1002/hed.23843] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
59 Wilkie MD, Chudek DA, Flynn CD, Gaskell P, Loh C, Tandon S, Roland NJ, Jones TM, Lancaster J. Outcomes and prognosticators in regionally recurrent cutaneous squamous cell carcinoma of the head and neck. Eur J Surg Oncol 2020;46:2035-41. [PMID: 32800595 DOI: 10.1016/j.ejso.2020.07.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Pang G, Look Hong NJ, Paull G, Dobransky J, Kupper S, Hurton S, Kagedan DJ, Quan ML, Helyer L, Nessim C, Wright FC. Squamous Cell Carcinoma with Regional Metastasis to Axilla or Groin Lymph Nodes: a Multicenter Outcome Analysis. Ann Surg Oncol 2019;26:4642-50. [PMID: 31440926 DOI: 10.1245/s10434-019-07743-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Kirke DN, Porceddu S, Wallwork BD, Panizza B, Coman WB. Pathologic Occult Neck Disease in Patients With Metastatic Cutaneous Squamous Cell Carcinoma to the Parotid. Otolaryngol Head Neck Surg 2011;144:549-51. [DOI: 10.1177/0194599810395361] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
62 Lewis CM, Glisson BS, Feng L, Wan F, Tang X, Wistuba II, El-Naggar AK, Rosenthal DI, Chambers MS, Lustig RA. A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neck. Clin Cancer Res. 2012;18:1435-1446. [PMID: 22261807 DOI: 10.1158/1078-0432.ccr-11-1951] [Cited by in Crossref: 123] [Cited by in F6Publishing: 35] [Article Influence: 13.7] [Reference Citation Analysis]
63 Gurudutt VV, Genden EM. Cutaneous squamous cell carcinoma of the head and neck. J Skin Cancer 2011;2011:502723. [PMID: 21461387 DOI: 10.1155/2011/502723] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
64 Porceddu SV, Bressel M, Poulsen MG, Stoneley A, Veness MJ, Kenny LM, Wratten C, Corry J, Cooper S, Fogarty GB, Collins M, Collins MK, Macann AMJ, Milross CG, Penniment MG, Liu HY, King MT, Panizza BJ, Rischin D. Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial. JCO 2018;36:1275-83. [DOI: 10.1200/jco.2017.77.0941] [Cited by in Crossref: 79] [Cited by in F6Publishing: 18] [Article Influence: 26.3] [Reference Citation Analysis]
65 Oddone N, Morgan GJ, Palme CE, Perera L, Shannon J, Wong E, Gebski V, Veness MJ. Metastatic cutaneous squamous cell carcinoma of the head and neck: The Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Cancer 2009;115:1883-91. [DOI: 10.1002/cncr.24208] [Cited by in Crossref: 87] [Cited by in F6Publishing: 80] [Article Influence: 7.3] [Reference Citation Analysis]
66 Fishbach S, Steinhardt G, Zhen CJ, Puranik R, Segal JP, Cipriani NA. High Rates of Ultraviolet-Signature Mutations in Squamous Cell Carcinomas of the Parotid Gland and Prognostic Implications. Head Neck Pathol 2021. [PMID: 34160783 DOI: 10.1007/s12105-021-01349-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Ritter A, Bachar G, Feinmesser R, Shpitzer T, Popovtzer A, Rabinovics N. Nonmelanoma skin cancer of the head and neck region in solid organ transplant recipients. Head & Neck 2018. [DOI: 10.1002/hed.25467] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
68 Wang AY, Palme CE, Wang JT, Morgan GJ, Gebski V, Gilchrist J, Veness MJ. Quality of life assessment in patients treated for metastatic cutaneous squamous cell carcinoma of the head and neck. J Laryngol Otol 2013;127 Suppl 2:S39-47. [PMID: 23458083 DOI: 10.1017/S0022215113000303] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
69 Veness MJ, Goedjen B, Jambusaria A. Perioperative Management of High Risk Primary Cutaneous Squamous Cell Carcinoma: Role of Radiologic Imaging, Elective Lymph Node Dissection, Sentinel Lymph Node Biopsy, and Adjuvant Radiotherapy. Curr Derm Rep 2013;2:77-83. [DOI: 10.1007/s13671-013-0041-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
70 O'hara J, Ferlito A, Takes RP, Rinaldo A, Strojan P, Shaha AR, Rodrigo JP, Paleri V, Eisele DW. Cutaneous squamous cell carcinoma of the head and neck metastasizing to the parotid gland-A review of current recommendations. Head Neck 2011;33:1789-95. [DOI: 10.1002/hed.21583] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
71 Farasat S, Yu SS, Neel VA, Nehal KS, Lardaro T, Mihm MC, Byrd DR, Balch CM, Califano JA, Chuang AY, Sharfman WH, Shah JP, Nghiem P, Otley CC, Tufaro AP, Johnson TM, Sober AJ, Liégeois NJ. A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol 2011;64:1051-9. [PMID: 21255868 DOI: 10.1016/j.jaad.2010.08.033] [Cited by in Crossref: 157] [Cited by in F6Publishing: 122] [Article Influence: 15.7] [Reference Citation Analysis]
72 Darr OA, Colacino JA, Tang AL, McHugh JB, Bellile EL, Bradford CR, Prince MP, Chepeha DB, Rozek LS, Moyer JS. Epigenetic alterations in metastatic cutaneous carcinoma. Head Neck 2015;37:994-1001. [PMID: 24700717 DOI: 10.1002/hed.23701] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
73 Forest V, Clark JJ, Veness MJ, Milross C. N1S3: A revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: Results of 2 Australian Cancer Centers. Cancer 2010;116:1298-304. [DOI: 10.1002/cncr.24855] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 6.4] [Reference Citation Analysis]
74 Kim S, Eleff M, Nicolaou N, Smith RB. Cetuximab as primary treatment for cutaneous squamous cell carcinoma to the neck. Head Neck 2011;33:286-8. [DOI: 10.1002/hed.21299] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
75 Kalapurakal SJ, Malone J, Robbins KT, Buescher L, Godwin J, Rao K. Cetuximab in refractory skin cancer treatment. J Cancer 2012;3:257-61. [PMID: 22712026 DOI: 10.7150/jca.3491] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
76 Lam JKS, Sundaresan P, Gebski V, Veness MJ. Immunocompromised patients with metastatic cutaneous nodal squamous cell carcinoma of the head and neck: Poor outcome unrelated to the index lesion. Head & Neck 2018;40:985-92. [DOI: 10.1002/hed.25069] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
77 Yilmaz M, Eskiizmir G, Friedman O. Cutaneous Squamous Cell Carcinoma of the Head and Neck. Facial Plastic Surgery Clinics of North America 2012;20:473-81. [DOI: 10.1016/j.fsc.2012.07.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
78 Wang JT, Palme CE, Morgan GJ, Gebski V, Wang AY, Veness MJ. Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: Improved survival with the addition of adjuvant radiotherapy. Head Neck 2012;34:1524-8. [PMID: 22109745 DOI: 10.1002/hed.21965] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 6.6] [Reference Citation Analysis]
79 Mooney CP, Clark JR, Shannon K, Palme CE, Ebrahimi A, Gao K, Ch'ng S, Elliott M, Gupta R, Low TH. The significance of regional metastasis location in head and neck cutaneous squamous cell carcinoma. Head Neck 2021;43:2705-11. [PMID: 34019319 DOI: 10.1002/hed.26744] [Reference Citation Analysis]
80 Manoukian MAC, Ott SV, Rajadas J, Inayathullah M. Polymeric Nanoparticles to Combat Squamous Cell Carcinomas in Patients with Dystrophic Epidermolysis Bullosa. Recent Pat Nanomed 2014;4:15-24. [PMID: 25506404 DOI: 10.2174/1877912304666140708184013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
81 Porceddu SV. Prognostic factors and the role of adjuvant radiation therapy in non-melanoma skin cancer of the head and neck. Am Soc Clin Oncol Educ Book 2015;:e513-8. [PMID: 25993217 DOI: 10.14694/EdBook_AM.2015.35.e513] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
82 Matthiesen C, Thompson S, Steele A, Thompson D, Ahmad S, Bogardus Jr C. Radiotherapy in treatment of carcinoma of the parotid gland, an approach for the medically or technically inoperable patient: Radiotherapy for parotid tumours. Journal of Medical Imaging and Radiation Oncology 2010;54:490-6. [DOI: 10.1111/j.1754-9485.2010.02202.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
83 Veness MJ. The important role of radiotherapy in patients with non-melanoma skin cancer and other cutaneous entities. J Med Imaging Radiat Oncol 2008;52:278-86. [PMID: 18477123 DOI: 10.1111/j.1440-1673.2008.01956.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
84 Mooney CP, Gao K, Clark JR, Gupta R, Shannon K, Palme CE, Ebrahimi A, Ch'ng S, Low TH. Soft Tissue Metastases in Head and Neck Cutaneous Squamous Cell Carcinoma. Laryngoscope 2021;131:E1209-13. [PMID: 32926433 DOI: 10.1002/lary.29064] [Reference Citation Analysis]
85 Ch'ng S, Clark JR, Brunner M, Palme CE, Morgan GJ, Veness MJ. Relevance of the primary lesion in the prognosis of metastatic cutaneous squamous cell carcinoma. Head Neck 2013;35:190-4. [DOI: 10.1002/hed.22941] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
86 South AP, O'Toole EA. Understanding the pathogenesis of recessive dystrophic epidermolysis bullosa squamous cell carcinoma. Dermatol Clin 2010;28:171-8. [PMID: 19945632 DOI: 10.1016/j.det.2009.10.023] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
87 Bonerandi JJ, Beauvillain C, Caquant L, Chassagne JF, Chaussade V, Clavère P, Desouches C, Garnier F, Grolleau JL, Grossin M, Jourdain A, Lemonnier JY, Maillard H, Ortonne N, Rio E, Simon E, Sei JF, Grob JJ, Martin L; French Dermatology Recommendations Association (aRED). Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions. J Eur Acad Dermatol Venereol 2011;25 Suppl 5:1-51. [PMID: 22070399 DOI: 10.1111/j.1468-3083.2011.04296.x] [Cited by in F6Publishing: 64] [Reference Citation Analysis]
88 Israel Y, Rachmiel A, Gourevich K, Nagler R. Non-primary salivary malignancies: A 22-year retrospective study. J Craniomaxillofac Surg 2019;47:1351-5. [PMID: 31331848 DOI: 10.1016/j.jcms.2019.06.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Wang JT, Palme CE, Wang AY, Morgan GJ, Gebski V, Veness MJ. In patients with metastatic cutaneous head and neck squamous cell carcinoma to cervical lymph nodes, the extent of neck dissection does not influence outcome. J Laryngol Otol 2013;127 Suppl 1:S2-7. [PMID: 23046820 DOI: 10.1017/S0022215112002101] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
90 Kampel L, Dorman A, Horovitz G, Warshavsky A, Gutfeld O, Muhanna N. The role of parotidectomy for advanced cutaneous squamous cell carcinoma of the head and neck. Eur Arch Otorhinolaryngol 2021;278:3955-63. [PMID: 33404750 DOI: 10.1007/s00405-020-06574-8] [Reference Citation Analysis]
91 Sand M, Sand D, Thrandorf C, Paech V, Altmeyer P, Bechara FG. Cutaneous lesions of the nose. Head Face Med 2010;6:7. [PMID: 20525327 DOI: 10.1186/1746-160X-6-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
92 Brunner M, Ng BC, Veness MJ, Clark JR. Assessment of the new nodal classification for cutaneous squamous cell carcinoma and its effect on patient stratification: Prognostic Value of N Classification in Cutaneous SCC. Head Neck 2015;37:336-9. [DOI: 10.1002/hed.23602] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
93 Gee HE, Veness MJ. High-Risk Cutaneous Squamous Cell Carcinoma. Curr Otorhinolaryngol Rep 2018;6:120-8. [DOI: 10.1007/s40136-018-0194-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
94 Kampel L, Dorman A, Horowitz G, Fliss DM, Gutfeld O, Muhanna N. Surgically Treated Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck: Outcome Predictors and the Role of Adjuvant Radiation Therapy. Ann Otol Rhinol Laryngol 2021;130:1016-23. [PMID: 33514267 DOI: 10.1177/0003489421990182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
95 Veness MJ. Time to rethink TNM staging in cutaneous SCC. Lancet Oncol 2008;9:702-3. [PMID: 18672208 DOI: 10.1016/S1470-2045(08)70185-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
96 Lin C, Ballah T, Nottage M, Hay K, Chua B, Kenny L, Thomas P, Teng M, Keller J, Le T, Edmunds J, Hughes B. A prospective study investigating the efficacy and toxicity of definitive ChemoRadiation and ImmunOtherapy (CRIO) in locally and/or regionally advanced unresectable cutaneous squamous cell carcinoma. Radiat Oncol 2021;16:69. [PMID: 33836800 DOI: 10.1186/s13014-021-01795-5] [Reference Citation Analysis]
97 Vasconcelos L, Melo JC, Miot HA, Marques ME, Abbade LP. Invasive head and neck cutaneous squamous cell carcinoma: clinical and histopathological characteristics, frequency of local recurrence and metastasis. An Bras Dermatol 2014;89:562-8. [PMID: 25054741 DOI: 10.1590/abd1806-4841.20142810] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
98 Bachar G, Mizrachi A, Rabinovics N, Guttman D, Shpitzer T, Ad-el D, Hadar T. Prognostic Factors in Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck. Ear Nose Throat J 2016;95:1-10. [DOI: 10.1177/0145561316095010-1106] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
99 South AP, Purdie KJ, Watt SA, Haldenby S, den Breems NY, Dimon M, Arron ST, Kluk MJ, Aster JC, McHugh A. NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis. J Invest Dermatol. 2014;134:2630-2638. [PMID: 24662767 DOI: 10.1038/jid.2014.154] [Cited by in Crossref: 194] [Cited by in F6Publishing: 176] [Article Influence: 27.7] [Reference Citation Analysis]
100 Myers LL, Ahn C. Cutaneous squamous cell carcinoma metastasis to the parotid region lymph nodes: Skin Cancer Metastasis to Parotid Region. The Laryngoscope 2019;129:1579-86. [DOI: 10.1002/lary.27534] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
101 Porceddu SV, Veness MJ, Guminski A. Nonmelanoma Cutaneous Head and Neck Cancer and Merkel Cell Carcinoma: Current Concepts, Advances, and Controversies. J Clin Oncol 2015;33:3338-45. [PMID: 26351348 DOI: 10.1200/JCO.2014.60.7333] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
102 Khan Z, Khan AA, Yadav H, Prasad GBKS, Bisen PS. Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma. Cell Mol Biol Lett. 2017;22:8. [PMID: 28536639 DOI: 10.1186/s11658-017-0038-0] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 12.8] [Reference Citation Analysis]
103 Howle JR, Morgan GJ, Kalnins I, Palme CE, Veness MJ. METASTATIC CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE SCALP. ANZ J Surg 2008;78:449-53. [DOI: 10.1111/j.1445-2197.2008.04533.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
104 Hirshoren N, Danne J, Dixon BJ, Magarey M, Kleid S, Webb A, Tiong A, Corry J, Gyorki D. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck. Head Neck 2017;39:772-8. [PMID: 28199044 DOI: 10.1002/hed.24683] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
105 Foley H, Hopley S, Brown E, Bernard A, Foote M. Conformal orbit sparing radiation therapy: a treatment option for advanced skin cancer of the parotid and ear region. J Med Radiat Sci 2016;63:186-94. [PMID: 27648283 DOI: 10.1002/jmrs.161] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
106 Dür C, Salmina C, Borner U, Giger R, Nisa L. Relevance of Intraparotid Metastases in Head and Neck Skin Squamous Cell Carcinoma. Laryngoscope 2021;131:788-93. [PMID: 32918494 DOI: 10.1002/lary.28985] [Reference Citation Analysis]
107 Liu J, Ebrahimi A, Low TH, Gao K, Palme CE, Sydney C, Ashford BG, Iyer NG, Clark JR, Gupta R. Predictive value of the 8th edition American Joint Commission Cancer (AJCC) nodal staging system for patients with cutaneous squamous cell carcinoma of the head and neck. J Surg Oncol 2018;117:765-72. [PMID: 29049841 DOI: 10.1002/jso.24883] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
108 Toppi J, Tham YS, Webb A, Henderson MA, Rischin D, Magarey MJR. Surgical management of recurrent cutaneous squamous cell carcinoma of the head and neck after definitive surgery and radiotherapy. ANZ J Surg 2020;90:1391-5. [PMID: 32627359 DOI: 10.1111/ans.16095] [Reference Citation Analysis]
109 Ritter A, Badir S, Mansour M, Segal Z, Ad-El D, Bachar G, Shpitzer T, Popovtzer A, Mizrachi A. Solid organ transplantation worsens the prognosis of patients with cutaneous squamous cell carcinoma of the head and neck region-Comparison between solid organ transplant recipients and immunocompetent patients. Head Neck 2021;43:884-94. [PMID: 33247523 DOI: 10.1002/hed.26546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Hinerman RW, Indelicato DJ, Amdur RJ, Morris CG, Werning JW, Vaysberg M, Kirwan J, Mendenhall WM. Cutaneous Squamous Cell Carcinoma Metastatic to Parotid-Area Lymph Nodes. Laryngoscope 2008;118:1989-96. [DOI: 10.1097/mlg.0b013e318180642b] [Cited by in Crossref: 71] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
111 Stevenson ML, Criscito MC, Wilken R, Doudican NA, Bain EE 3rd, Parashar B, Carucci JA. Use of Adjuvant Radiotherapy in the Treatment of High-risk Cutaneous Squamous Cell Carcinoma With Perineural Invasion. JAMA Dermatol 2020;156:918-21. [PMID: 32609298 DOI: 10.1001/jamadermatol.2020.1984] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
112 Hoffman GR, Jefferson ND, Reid CB, Eisenberg RL. Orbital Exenteration to Manage Infiltrative Sinonasal, Orbital Adnexal, and Cutaneous Malignancies Provides Acceptable Survival Outcomes: An Institutional Review, Literature Review, and Meta-Analysis. J Oral Maxillofac Surg. 2016;74:631-643. [PMID: 26475973 DOI: 10.1016/j.joms.2015.09.019] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
113 Newman JG, Hall MA, Kurley SJ, Cook RW, Farberg AS, Geiger JL, Koyfman SA. Adjuvant therapy for high-risk cutaneous squamous cell carcinoma: 10-year review. Head Neck 2021;43:2822-43. [PMID: 34096664 DOI: 10.1002/hed.26767] [Reference Citation Analysis]
114 Huo M, Panizza B, Bernard A, Porceddu SV. Head and neck squamous cell carcinoma of unknown primary: Outcomes of a pre-defined institutional treatment policy in a region with a high prevalence of skin cancer. Oral Oncol 2018;77:43-8. [PMID: 29362125 DOI: 10.1016/j.oraloncology.2017.12.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
115 Pedersen TØ, Lybak S, Lund B, Løes S. Temporomandibular joint prosthesis in cancer reconstruction preceding radiation therapy. Clin Case Rep 2021;9:1438-41. [PMID: 33768862 DOI: 10.1002/ccr3.3794] [Reference Citation Analysis]
116 . Carcinome épidermoïde cutané (carcinome spinocellulaire) : Recommandations de pratique clinique pour la prise en charge diagnostique et thérapeutique Argumentaire - Mai 2009. Annales de Dermatologie et de Vénéréologie 2009;136:S189-242. [DOI: 10.1016/s0151-9638(09)75172-5] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
117 Cheng J, Yan S. Prognostic variables in high-risk cutaneous squamous cell carcinoma: a review. J Cutan Pathol 2016;43:994-1004. [PMID: 27404896 DOI: 10.1111/cup.12766] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
118 Klasser GD, Epstein JB, Utsman R, Yao M, Nguyen PH. Parotid Gland Squamous Cell Carcinoma Invading the Temporomandibular Joint. The Journal of the American Dental Association 2009;140:992-9. [DOI: 10.14219/jada.archive.2009.0309] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
119 Nasser QJ, Roth KG, Warneke CL, Yin VT, El Sawy T, Esmaeli B. Impact of AJCC ‘T’ designation on risk of regional lymph node metastasis in patients with squamous carcinoma of the eyelid. Br J Ophthalmol 2014;98:498-501. [DOI: 10.1136/bjophthalmol-2013-304434] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
120 Bumpous J. Metastatic cutaneous squamous cell carcinoma to the parotid and cervical lymph nodes: treatment and outcomes. Current Opinion in Otolaryngology & Head & Neck Surgery 2009;17:122-5. [DOI: 10.1097/moo.0b013e32832924e0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
121 Gurney B, Newlands C. Management of regional metastatic disease in head and neck cutaneous malignancy. 1. Cutaneous squamous cell carcinoma. Br J Oral Maxillofac Surg 2014;52:294-300. [PMID: 24559975 DOI: 10.1016/j.bjoms.2014.01.015] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]